Login| Sign Up| Help| Contact|

Patent Searching and Data

Document Type and Number:
Japanese Patent JP2002500677
Kind Code:
The present invention relates to a method of achieving significant improvement in the glycaemic control by the combined use of a short-acting hypoglycemic agent, such as repaglinide, and metformin in NIDDM patients poorly controlled on metformin alone.

Hemingsen, Lisbeth Tofte
Muller, Peter Jolts
Application Number:
Publication Date:
January 08, 2002
Filing Date:
June 12, 1998
Export Citation:
Click for automatic bibliography generation   Help
Novo Nordisk Actiesel Scab
International Classes:
A61K45/00; A61K31/00; A61K31/15; A61K31/155; A61K31/18; A61K31/195; A61K31/198; A61K31/403; A61K31/425; A61K31/427; A61K31/445; A61K31/4453; A61K31/451; A61K31/47; A61K31/472; A61K31/4965; A61K31/50; A61K31/64; A61P3/10; A61P43/00; A61K; (IPC1-7): A61K45/00; A61K31/155; A61K31/18; A61K31/198; A61K31/403; A61K31/427; A61K31/4453; A61K31/472; A61K31/4965; A61K31/50; A61P3/10; A61P43/00
Attorney, Agent or Firm:
Takehiko Suzue (4 outside)